Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03405311 · ClinicalTrials.gov registry record · NA
3D Ultrasound-guided Labor Epidural Analgesia in the Morbid Obese Parturient
A NA study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03405311 is a NA study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 40 participants.
The verdict
NCT03405311, a NA study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study will be a randomized control study, with the objective to evaluate epidural analgesia success rates between the two methods (Blind Approach versus Accuro Device).
Interventions
- OTHER Palpation
- DEVICE Rivanna Accuro 3D Ultrasound Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-02-20 |
| Est. Completion | 2024-01-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03405311
The ClinicalTrials.gov registry entry for NCT03405311 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Palpation is the first listed.
NCT03405311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03405311 about?
NCT03405311 is a clinical study titled "3D Ultrasound-guided Labor Epidural Analgesia in the Morbid Obese Parturient". This study will be a randomized control study, with the objective to evaluate epidural analgesia success rates between the two methods (Blind Approach versus Accuro Device).
What is the current status of trial NCT03405311?
This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2018-02-20. Estimated completion is 2024-01-11.
What interventions are being tested in trial NCT03405311?
The interventions under investigation include: Palpation (OTHER), Rivanna Accuro 3D Ultrasound Device (DEVICE).
Who is sponsoring clinical trial NCT03405311?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.